Treace Medical Concepts Stock Filter Stocks by Fundamentals
| TMCI Stock | USD 8.78 0.26 3.05% |
Treace Medical Concepts fundamentals help investors to digest information that contributes to Treace Medical's financial success or failures. It also enables traders to predict the movement of Treace Stock. The fundamental analysis module provides a way to measure Treace Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Treace Medical stock.
Treace | Shares Owned by Institutions |
Treace Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Treace Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Treace Medical's managers, analysts, and investors.Environmental | Governance | Social |
Treace Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Treace Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Treace Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Treace Medical's value.| Shares | State Street Corp | 2024-09-30 | 997.5 K | Soleus Capital Management, L.p. | 2024-09-30 | 887.9 K | Kent Lake Capital Llc | 2024-06-30 | 750 K | Goldman Sachs Group Inc | 2024-09-30 | 665.2 K | Millennium Management Llc | 2024-09-30 | 554.5 K | Kornitzer Capital Management Inc | 2024-09-30 | 526.9 K | Gagnon Advisors, Llc | 2024-09-30 | 489.9 K | Northern Trust Corp | 2024-09-30 | 458.2 K | Marshall Wace Asset Management Ltd | 2024-09-30 | 426.7 K | Armistice Capital, Llc | 2024-09-30 | 6.2 M | Blackrock Inc | 2024-06-30 | 4.1 M |
Treace Fundamentals
| Return On Equity | -0.51 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (0.30) % | ||||
| Operating Margin | (0.34) % | ||||
| Current Valuation | 518.09 M | ||||
| Shares Outstanding | 62.3 M | ||||
| Shares Owned By Insiders | 24.82 % | ||||
| Shares Owned By Institutions | 64.34 % | ||||
| Number Of Shares Shorted | 2.99 M | ||||
| Price To Book | 5.06 X | ||||
| Price To Sales | 2.63 X | ||||
| Revenue | 187.12 M | ||||
| Gross Profit | 114.31 M | ||||
| EBITDA | (39.01 M) | ||||
| Net Income | (49.53 M) | ||||
| Cash And Equivalents | 101.53 M | ||||
| Cash Per Share | 1.83 X | ||||
| Total Debt | 70.3 M | ||||
| Debt To Equity | 0.99 % | ||||
| Current Ratio | 8.13 X | ||||
| Book Value Per Share | 1.69 X | ||||
| Cash Flow From Operations | (34.58 M) | ||||
| Short Ratio | 4.19 X | ||||
| Earnings Per Share | (0.99) X | ||||
| Target Price | 7.5 | ||||
| Number Of Employees | 516 | ||||
| Beta | 0.24 | ||||
| Market Capitalization | 533.26 M | ||||
| Total Asset | 251.91 M | ||||
| Retained Earnings | (134.25 M) | ||||
| Working Capital | 153.33 M | ||||
| Net Asset | 251.91 M |
About Treace Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Treace Medical Concepts's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Treace Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Treace Medical Concepts based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Treace Medical Concepts offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock:Check out Treace Medical Piotroski F Score and Treace Medical Altman Z Score analysis. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.99) | Revenue Per Share 3.274 | Quarterly Revenue Growth 0.106 | Return On Assets (0.17) | Return On Equity (0.51) |
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.